Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer-myositis connection

Prognostic Significance of TRIM24/TIF-1α Gene Expression in Breast Cancer

(2011) Monique Chambon et al.   AMERICAN JOURNAL OF PATHOLOGY

Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins

(2011) Manabu Fujimoto et al.   ARTHRITIS AND RHEUMATISM

Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins

(2011) Taro Kawai et al.   EMBO Molecular Medicine

KAP1 Protein: An Enigmatic Master Regulator of the Genome

(2011) Sushma Iyengar et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study

(2011) David Fiorentino et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Recruitment of TIF1γ to Chromatin via Its PHD Finger-Bromodomain Activates Its Ubiquitin Ligase and Transcriptional Repressor Activities

(2011) Eleonora Agricola et al.   MOLECULAR CELL

Malignancy and myositis: novel autoantibodies and new insights

(2010) Albert Selva-OʼCallaghan et al.   CURRENT OPINION IN RHEUMATOLOGY

TRIM24 links a non-canonical histone signature to breast cancer

(2010) Wen-Wei Tsai et al.   NATURE

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

(2009) Shinji Sato et al.   ARTHRITIS AND RHEUMATISM

Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer

(2009) G Kijanka et al.   GUT

KAP1 regulates type I interferon/STAT1-mediated IRF-1 gene expression

(2008) Shinya Kamitani et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS